Literature DB >> 20117109

Absence of mitogen-activated protein kinase family member c-Jun N-terminal kinase-2 enhances resistance to Toxoplasma gondii.

Woraporn Sukhumavasi1, Amy L Warren, Laura Del Rio, Eric Y Denkers.   

Abstract

The function of mitogen-activated protein kinase (MAPK) family member c-Jun N-terminal kinase (JNK)-2 in resistance and pathology during infection has not been greatly studied. Here, we employed Jnk2(-/-) mice to investigate the role of JNK2 in resistance and immunity during oral infection with the protozoan pathogen Toxoplasma gondii. We found increased host resistance in the absence of JNK2 as determined by lower parasite burden and increased host survival. Lack of JNK2 also correlated with decreased neutrophil recruitment to the intestinal mucosa and less pathology in the small intestine. In the absence of JNK2, IL-12 production was slightly but significantly increased in restimulated splenocyte populations as well as in purified splenic dendritic cell cultures. These results provide evidence that expression of JNK2 plays a role in T. gondii-induced immunopathology, at the same time in promoting susceptibility to this parasitic pathogen. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117109      PMCID: PMC2891872          DOI: 10.1016/j.exppara.2010.01.019

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  29 in total

1.  Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.

Authors:  G Cai; T Radzanowski; E N Villegas; R Kastelein; C A Hunter
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

Review 2.  Toxoplasmosis in pregnancy.

Authors:  Jeffrey D Kravetz; Daniel G Federman
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965

3.  STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis.

Authors:  Linda A Lieberman; Monica Banica; Steven L Reiner; Christopher A Hunter
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

4.  Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors.

Authors:  Wei Ma; Katrina Gee; Wilfred Lim; Kelly Chambers; Jonathan B Angel; Maya Kozlowski; Ashok Kumar
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

5.  c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production.

Authors:  Mitsuyoshi Utsugi; Kunio Dobashi; Tamotsu Ishizuka; Katsuaki Endou; Junji Hamuro; Yukie Murata; Tsugio Nakazawa; Masatomo Mori
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

Review 6.  Toxoplasmic encephalitis in AIDS.

Authors:  B J Luft; J S Remington
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

7.  STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection.

Authors:  L Cristina Gavrilescu; Barbara A Butcher; Laura Del Rio; Gregory A Taylor; Eric Y Denkers
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Ventilation-induced neutrophil infiltration depends on c-Jun N-terminal kinase.

Authors:  Li-Fu Li; Lunyin Yu; Deborah A Quinn
Journal:  Am J Respir Crit Care Med       Date:  2003-11-25       Impact factor: 21.405

9.  c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.

Authors:  Nathalie Arbour; Denise Naniche; Dirk Homann; Roger J Davis; Richard A Flavell; Michael B A Oldstone
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

10.  c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation.

Authors:  Dietrich Conze; Troy Krahl; Norman Kennedy; Linda Weiss; Joanne Lumsden; Patricia Hess; Richard A Flavell; Graham Le Gros; Roger J Davis; Mercedes Rincón
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

View more
  4 in total

1.  JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.

Authors:  Jianyun Liu; Richard M Gallo; Masood A Khan; Abhirami K Iyer; Ian M Kratzke; Randy R Brutkiewicz
Journal:  Eur J Immunol       Date:  2018-12-03       Impact factor: 5.532

2.  Toxoplasma gondii induces B7-2 expression through activation of JNK signal transduction.

Authors:  Pedro Morgado; Yi-Ching Ong; John C Boothroyd; Melissa B Lodoen
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

3.  Reduced parasite motility and micronemal protein secretion by a p38 MAPK inhibitor leads to a severe impairment of cell invasion by the apicomplexan parasite Eimeria tenella.

Authors:  Françoise I Bussière; Fabien Brossier; Yves Le Vern; Alisson Niepceron; Anne Silvestre; Thibaut de Sablet; Sonia Lacroix-Lamandé; Fabrice Laurent
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

4.  Intracellular Networks of the PI3K/AKT and MAPK Pathways for Regulating Toxoplasma gondii-Induced IL-23 and IL-12 Production in Human THP-1 Cells.

Authors:  Juan-Hua Quan; Jia-Qi Chu; Jaeyul Kwon; In-Wook Choi; Hassan Ahmed Hassan Ahmed Ismail; Wei Zhou; Guang-Ho Cha; Yu Zhou; Jae-Min Yuk; Eun-Kyeong Jo; Young-Ha Lee
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.